[{"AccountsPayableCurrent_0_Q2_USD":506000000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-297000000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":167000000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":-238000000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1_Q2_USD":-3000000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_2_Q2_USD":-11000000.0,"OtherLiabilitiesCurrent_0_Q2_USD":502000000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":169000000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":237000000.0,"OtherReceivablesNetCurrent_0_Q2_USD":107000000.0,"PaymentsForProceedsFromOtherInvestingActivities_2_Q2_USD":7000000.0,"PaymentsForRestructuring_2_Q2_USD":70000000.0,"PaymentsForSoftware_2_Q2_USD":12000000.0,"PaymentsOfDebtIssuanceCosts_2_Q2_USD":0.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_2_Q2_USD":-73000000.0,"OtherOperatingActivitiesCashFlowStatement_2_Q2_USD":0.0,"PaymentsToAcquireIntangibleAssets_2_Q2_USD":34000000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_2_Q2_USD":48000000.0,"OtherAssetsNoncurrent_0_Q2_USD":375000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":16833000000.0,"LiabilitiesCurrent_0_Q2_USD":1990000000.0,"LitigationReserve_0_Q2_USD":0.0,"LongTermDebt_0_Q2_USD":6097000000.0,"LongTermDebtCurrent_0_Q2_USD":555000000.0,"LongTermDebtNoncurrent_0_Q2_USD":5542000000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1_Q2_USD":-5000000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-65000000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":171000000.0,"NetIncomeLoss_1_Q2_USD":-210000000.0,"NetIncomeLoss_2_Q2_USD":-271000000.0,"NonoperatingIncomeExpense_1_Q2_USD":3000000.0,"NonoperatingIncomeExpense_2_Q2_USD":3000000.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-15000000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":35000000.0,"PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_0_Q2_USD":317000000.0,"PreferredStockSharesAuthorized_0_Q2_shares":1000000000.0,"RestructuringSettlementAndImpairmentProvisions_2_Q2_USD":407000000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-748000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":1279000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":2521000000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":385000000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":733000000.0,"RestructuringSettlementAndImpairmentProvisions_1_Q2_USD":299000000.0,"SeveranceCosts1_1_Q2_USD":1000000.0,"ShareBasedCompensation_2_Q2_USD":31000000.0,"StockholdersEquity_0_Q2_USD":7980000000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q2_shares":0.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_2_Q2_shares":0.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":487300000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":487000000.0,"SeveranceCosts1_2_Q2_USD":28000000.0,"RestructuringReserveAccrualAdjustment1_2_Q2_USD":-14000000.0,"RestructuringReserveAccrualAdjustment1_1_Q2_USD":-1000000.0,"RestructuringReserve_0_Q2_USD":88000000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockValue_0_Q2_USD":0.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":227000000.0,"ProceedsFromHedgeInvestingActivities_2_Q2_USD":0.0,"ProceedsFromIssuanceOfSeniorLongTermDebt_2_Q2_USD":0.0,"ProceedsFromIssuanceOrSaleOfEquity_2_Q2_USD":0.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q2_USD":-17000000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":1033000000.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1_Q2_USD":-7000000.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2_Q2_USD":14000000.0,"RepaymentsOfLongTermLinesOfCredit_2_Q2_USD":37000000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":94000000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":183000000.0,"RestrictedCashCurrent_0_Q2_USD":0.0,"RestructuringCharges_2_Q2_USD":42000000.0,"Liabilities_0_Q2_USD":8853000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":487300000.0,"InventoryWorkInProcess_0_Q2_USD":662000000.0,"InventoryNet_0_Q2_USD":1450000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":74000000.0,"CommitmentsAndContingencies_0_Q2_USD":0.0,"CommonStockSharesAuthorized_0_Q2_shares":5000000000.0,"CommonStockSharesIssued_0_Q2_shares":473003487.0,"CommonStockSharesOutstanding_0_Q2_shares":473003487.0,"CommonStockValue_0_Q2_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":580000000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-43000000.0,"ContractWithCustomerLiability_0_Q2_USD":303000000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":303000000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q2_USD":178000000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":367000000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":551000000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":1120000000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-509000000.0,"CostsAndExpenses_1_Q2_USD":1515000000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":580000000.0,"BusinessExitCosts1_1_Q2_USD":0.0,"AccountsReceivableNetCurrent_0_Q2_USD":1067000000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":1054000000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":65000000.0,"AdditionalPaidInCapital_0_Q2_USD":8663000000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":16000000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":10000000.0,"BusinessExitCosts1_2_Q2_USD":0.0,"AmortizationOfIntangibleAssets_1_Q2_USD":129000000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":1400000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":1500000.0,"Assets_0_Q2_USD":16833000000.0,"AssetsCurrent_0_Q2_USD":3431000000.0,"BusinessCombinationIntegrationRelatedCosts_1_Q2_USD":30000000.0,"BusinessCombinationIntegrationRelatedCosts_2_Q2_USD":111000000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":276000000.0,"CostsAndExpenses_2_Q2_USD":2837000000.0,"DeferredFinanceCostsNet_0_Q2_USD":90000000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":-114000000.0,"ImpairmentOfLongLivedAssetsToBeDisposedOf_1_Q2_USD":4000000.0,"ImpairmentOfLongLivedAssetsToBeDisposedOf_2_Q2_USD":13000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-236000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-316000000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-26000000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-45000000.0,"Goodwill_0_Q2_USD":6239000000.0,"IncreaseDecreaseInOperatingCapital_2_Q2_USD":190000000.0,"InterestExpense_1_Q2_USD":60000000.0,"InterestExpense_2_Q2_USD":121000000.0,"InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_0_Q2_USD":-27000000.0,"InventoryFinishedGoods_0_Q2_USD":599000000.0,"InventoryGross_0_Q2_USD":1488000000.0,"InventoryLIFOReserve_0_Q2_USD":38000000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":5755000000.0,"GainLossOnSaleOfOtherAssets_2_Q2_USD":-2000000.0,"GainLossOnDispositionOfAssets_2_Q2_USD":0.0,"GainLossOnDispositionOfAssets_1_Q2_USD":0.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":767000000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":372000000.0,"DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_1_Q2_USD":3000000.0,"DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_2_Q2_USD":14000000.0,"DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_1_Q2_USD":267000000.0,"DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_2_Q2_USD":269000000.0,"EarningsPerShareBasic_1_Q2_USD":-0.43,"EarningsPerShareBasic_2_Q2_USD":-0.56,"EarningsPerShareDiluted_1_Q2_USD":-0.43,"EarningsPerShareDiluted_2_Q2_USD":-0.56,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.111,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.142,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-17000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":124000000.0,"EquityMethodInvestments_0_Q2_USD":18000000.0,"InventoryRawMaterialsAndSupplies_0_Q2_USD":227000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":487000000.0,"Ticker":"ELAN","CIK":"1739104","name":"ELANCO ANIMAL HEALTH INC","OfficialName":"Elanco Animal Health Incorporated Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"12367077748.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20210809"}]